Clinical Trial Update: Safety and Pk Study in 1- to 3- Month-Old Children With Bronchiolitis (0476-297) [Phase 2]

View source ↗

Summary

Phase 2 safety and pharmacokinetics study in 1- to 3-month-old children with bronchiolitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis

Snippet

Sponsor: Organon and Co | Conditions: Bronchiolitis | Phase 2 | Status: COMPLETED